You are here

  • Home
  • Archive
  • Volume 74, Issue 2
  • Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up

Authors

  • Eva L Kneepkens Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • James Cheng-Chung Wei Departments of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Michael T Nurmohamed Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Kai-Jieh Yeo Departments of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • C Y Chen Departments of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan PubMed articlesGoogle scholar articles
  • Irene E van der Horst-Bruinsma Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Rheumatology, VU University Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Desiree van der Kleij Laboratory for Monoclonal Therapeutics, Sanquin Diagnostic Services, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Theo Rispens Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Gertjan Wolbink Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Charlotte L M Krieckaert Department of Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Eva-Linda Kneepkens, Department of Rheumatology, Jan van Breemen Research Institute | Reade, Dr Jan van Breemenstraat 2, Amsterdam 1056 AB, The Netherlands; e.kneepkens{at}reade.nl
View Full Text

Citation

Kneepkens EL, Wei JC, Nurmohamed MT, et al
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up
Annals of the Rheumatic Diseases 2015;74:396-401.

Publication history

  • Received June 27, 2013
  • Revised September 3, 2013
  • Accepted November 5, 2013
  • First published December 10, 2013.
Online issue publication 
January 07, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions